EUVIMEDEUVIMED entdecken
Open Access

Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes

Yuka Natsuki, Tomoaki Morioka, Yoshinori Kakutani, Yuko Yamazaki, Akinobu Ochi, Masafumi Kurajoh, Katsuhito Mori, Yasuo Imanishi, Tetsuo Shoji, Masaaki Inaba, Masanori Emoto

Journal of Atherosclerosis and Thrombosis · 2023

DOI: 10.5551/jat.64000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2023. Verfasst von Yuka Natsuki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Renal Insufficiency, ChronicHumansFibroblast Growth Factor-23Muscle, Smooth, VascularCross-Sectional StudiesFibroblast Growth FactorsPhosphatesGlomerular Filtration Rate

Stichwörter der Autor:innen

Fibroblast Growth Factor 23Flow-Mediated DilatationNitroglycerin-Mediated DilatationType 2 Diabetes

Substanzen

Fibroblast Growth Factor-23Fibroblast Growth FactorsPhosphates

Autor:innen und Institutionen

  • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine.
  • Department of Nephrology, Osaka Metropolitan University Graduate School of Medicine.
  • Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine.
  • Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine.

Zitieren

APA

Natsuki, Y., Morioka, T., Kakutani, Y., Yamazaki, Y., Ochi, A., Kurajoh, M., Mori, K., Imanishi, Y., Shoji, T., Inaba, M., & Emoto, M. (2023). Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64000

Vancouver

Natsuki Y, Morioka T, Kakutani Y, Yamazaki Y, Ochi A, Kurajoh M, et al. Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 2023. doi:10.5551/jat.64000

BibTeX
@article{Natsuki2023,
  author = {Natsuki, Yuka and Morioka, Tomoaki and Kakutani, Yoshinori and Yamazaki, Yuko and Ochi, Akinobu and Kurajoh, Masafumi and Mori, Katsuhito and Imanishi, Yasuo and Shoji, Tetsuo and Inaba, Masaaki and Emoto, Masanori},
  title = {Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2023},
  doi = {10.5551/jat.64000}
}
Kostenlos starten →